13-dihydrodaunorubicin

Term ID

CHEBI:31059

Synonyms

(1S,3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
1-Hydroxy-13-dihydrodaunomycin
13-Dihydrodaunomycin
Antibiotic 20-798RP
Daunomycinol
Daunorubicinol
Dihydrodaunomycin
Duborimycin
Leukaemomycin D

Definition

An aminoglycoside antibiotic that is (1S,3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene having a 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl residue attached at position 1 via a glycosidic linkage.

References

CAS:28008-55-1
KEGG:C12430
LIPID_MAPS_instance:LMPK13050004
PMID:9098063
PMID:9864343
Reaxys:6773802

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

is a type of: aminoglycoside antibiotic anthracycline deoxy hexoside monosaccharide derivative p-quinones

aminoglycoside antibiotic anthracycline deoxy hexoside monosaccharide derivative p-quinones Show first 5 Terms
has subtype: (13S)-13-dihydrodaunorubicin

(13S)-13-dihydrodaunorubicin Show first 5 Terms
has_parent_hydride: tetracene

tetracene Show first 5 Terms
inverse is_conjugate_acid_of: 13-dihydrodaunorubicin(1+)

13-dihydrodaunorubicin(1+) Show first 5 Terms
is_conjugate_base_of: 13-dihydrodaunorubicin(1+)

13-dihydrodaunorubicin(1+) Show first 5 Terms

Phenotype

Phenotype resulting from 13-dihydrodaunorubicin

Phenotype where environments contain 13-dihydrodaunorubicin

Phenotype modified by environments containing 13-dihydrodaunorubicin

Human Disease Model